@article{discovery10122084,
           title = {Lower vitamin D is associated with metabolic syndrome and insulin resistance in systemic lupus: data from an international inception cohort},
            year = {2021},
         journal = {Rheumatology},
          number = {10},
           month = {October},
           pages = {4737--4747},
          volume = {60},
            note = {This version is the author accepted manuscript. For information on re-use, please refer to the publisher's terms and conditions.},
        keywords = {Systemic lupus erythematosus, cardiovascular disease, epidemiology, vitamin D},
          author = {Chew, C and Reynolds, JA and Lertratanakul, A and Wu, P and Urowitz, M and Gladman, DD and Fortin, PR and Bae, S-C and Gordon, C and Clarke, AE and Bernatsky, S and Hanly, JG and Isenberg, D and Rahman, A and Sanchez-Guerrero, J and Romero-Diaz, J and Merrill, J and Wallace, D and Ginzler, E and Khamashta, M and Nived, O and J{\"o}nsen, A and Steinsson, K and Manzi, S and Kalunian, K and Dooley, MA and Petri, M and Aranow, C and van Vollenhoven, R and Stoll, T and Alarc{\'o}n, GS and Lim, SS and Ruiz-Irastorza, G and Peschken, CA and Askanase, AD and Kamen, DL and {\.I}nan{\cc}, M and Ramsey-Goldman, R and Bruce, IN},
        abstract = {OBJECTIVES: Vitamin D (25(OH)D) deficiency and metabolic syndrome (MetS) may both contribute to increased cardiovascular risk in systemic lupus erythematosus (SLE). We aimed to examine the association of demographic factors, SLE phenotype, therapy and vitamin D levels with MetS and insulin resistance. METHODS: The Systemic Lupus International Collaborating Clinics (SLICC) enrolled patients recently diagnosed with SLE ({\ensuremath{<}}15 months) from 33 centres across 11 countries from 2000. Clinical, laboratory and therapeutic data were collected. Vitamin D level was defined according to tertiles based on distribution across this cohort, which were set at T1 (10-36 nmol/l), T2 (37-60 nmol/l) and T3 (61-174 nmol/l). MetS was defined according to the 2009 consensus statement from the International Diabetes Federation. Insulin resistance was determined using the HOMA-IR model. Linear and logistic regressions were used to assess the association of variables with vitamin D levels. RESULTS: Of the 1847 patients, 1163 (63\%) had vitamin D measured and 398 (34.2\%) subjects were in the lowest 25(OH)D tertile. MetS was present in 286 of 860 (33\%) patients whose status could be determined. Patients with lower 25(OH)D were more likely to have MetS and higher HOMA-IR. The MetS components, hypertension, hypertriglyceridemia and decreased HDL were all significantly associated with lower 25(OH)D. Increased average glucocorticoid exposure was associated with higher insulin resistance. CONCLUSIONS: MetS and insulin resistance are associated with lower vitamin D in patients with SLE. Further studies could determine whether vitamin D repletion confers better control of these cardiovascular risk factors and improve long-term outcomes in SLE.},
             url = {https://doi.org/10.1093/rheumatology/keab090}
}